Craniomaxillofacial implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral, and jaw surgeries. Craniomaxillofacial implants may be used to treat any congenital disease, facial deformity, or for aesthetic purposes. These can be either placed permanently or temporarily in the body and can be removed when they are no longer needed.
World craniomaxillofacial implants market is driven by several factors such as increase in demand for minimally invasive reconstruction surgeries, technological advancements, and increase in number of trauma cases, road accidents, and rise in prevalence rate of congenital facial deformities. For example: according to World Health Organization, the prevalence rate of cleft lip with or without cleft palate is 2.28 per 10,000 in Bolivia and the prevalence rate of cleft palate is 10.0 to 14.0 per 10,000 in Finland. On the other hand, high cost and risk associated with the implant malfunction has restricted the market growth.
The report segments the world craniomaxillofacial implants market based on product, application site, raw material, property, and geography. Based on product, the market is categorized into mid face implants, cranial or neuro implants, mandibular orthognathic implants, distraction systems, bone graft substitutes, thoracic fixation systems, total TMJ replacement systems, dural repair products, and cranial flap fixation systems. On the basis of raw materials, market is divided into polymers, ceramics, metals and biomaterials. On the basis of application site, the implants are classified into internal fixators and external fixators. On the basis of property, craniomaxillofacial implants can be resorbable fixators and non-resorbable. Based on geography, the market is divided into North America, Europe, Asia-Pacific, and LAMEA regions.
The world craniomaxillofacial implants market has witnessed product launches in the recent years. For example: Stryker Corporation has launched new technologically advanced craniomaxillofacial implants. In addition, DePuy Synthes (a wholly owned subsidiary of Johnson & Johnson) collaborated with Materialise, a Belgium based 3D printing company to develop patient-specific titanium based craniomaxillofacial implants.
Key players that operate in the world craniomaxillofacial implants market include Stryker Corporation, Johnson & Johnson, Zimmer Biomet Holdings, Inc., Medtronic plc, Integra LifeSciences Holdings Corporation, OsteoMed L.P., Medartis AG, KLS Martin, Calavera Surgical Design, and Matrix Surgical USA.
KEY MARKET BENEFITS:
The study provides an in-depth analysis of the world craniomaxillofacial implants market with current trends and future estimations to elucidate the imminent investment pockets.
The report provides a quantitative analysis, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Extensive analysis by product helps understand the various types of implants and their uses.
Comprehensive analysis of all geographic regions are provided that predicts the prevailing opportunities in these geographies.
Key market players within the world craniomaxillofacial implants market are profiled in the report and their strategies are analyzed thoroughly, which interprets competitive outlook of the global market.
Craniomaxillofacial Implants Market, by Product Report Highlights
| Aspects | Details |
 By Product |
|
 By Raw Material |
|
 By Application Site |
|
 By Property |
|
 By Region |
|
 Key Market Players | Johnson & Johnson, OsteoMed L.P., KLS Martin, Matrix Surgical USA., Integra LifeSciences Holdings Corporation, Zimmer Biomet Holdings, Inc., Stryker Corporation, Medartis AG, Calavera Surgical Design, Medtronic plc |
Loading Table Of Content...
